VF
TSHA icon

Virtu Financial’s Taysha Gene Therapies TSHA Stock Holding History

Virtu Financial’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60K Buy
+13,346
New +$62.1K ﹤0.01% 1261
2025
Q4 		– Sell
-48,123
Closed -$157K – 2247
2025
Q3 		$157K Buy
+48,123
New +$136K 0.01% 962
2025
Q1 		– Sell
-107,544
Closed -$186K – 2048
2024
Q4 		$186K Buy
+107,544
New +$223K 0.01% 912
2024
Q3 		– Sell
-57,191
Closed -$128K – 1897
2024
Q2 		$128K Buy
+57,191
New +$166K 0.01% 794
2024
Q1 		– Sell
-26,070
Closed -$46K – 2112
2023
Q4 		$46K Buy
+26,070
New +$52K ﹤0.01% 1187
2023
Q2 		– Sell
-45,459
Closed -$36K – 2052
2023
Q1 		$36K Buy
+45,459
New +$58.7K ﹤0.01% 1152

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM